Glycopyrrolate

규격

596-51-0CAS 번호

209-887-0EC 번호

(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate bromideIUPAC 명칭

C19H28BrNO3화학식

398.3 g/mol분자량

GLYCOPYRROLATE; 596-51-0; glycopyrronium bromide; Robinul; Nodapton; Tarodyl; Tarodyn; Cuvposa; Robanul; Glycopyrronii bromidum; Bromuro de glicopirronio; Bromure de glycopyrronium; Seebri; ROBINUL FORTE; Seebri Neohaler; AHR-504; 1,1-Dimethyl-3-hydroxypyrrolidinium bromide alpha-cyclopentylmandelate; NVA 237; NVA-237; Glycopyrrolate, erythro-; AD-237; PT-001; NSC-250836; NSC-251251; NSC-251252; 1-Methyl-3-pyrrolidyl alpha-phenylcyclopentaneglycolate methobromide; Glycopyrronium (as bromide); 3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate; NVA237; CHEBI:90972; CHF5259; PT001; CHF-5259; NSC250836; NSC251251; NSC251252; Org-NC-45; Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, alpha-cyclopentylmandelate; Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide; GLYRX-PF; LONHALA MAGNAIR KIT; glycate; sialanar; Robinul fte; BREZTRI COMPONENT GLYCOPYRROLATE; PREVDUO COMPONENT GLYCOPYRROLATE; Robinul-V Injectable; DARTISLA ODT; TRIMBOW COMPONENT GLYCOPYRRONIUM BROMIDE; ULTIBRO COMPONENT GLYCOPYRRONIUM BROMIDE; Bromide, Glycopyrronium; glycopyrronium (cation); 3-((2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy)-1,1-dimethylpyrrolidin-1-ium; BEVESPI AEROSPHERE COMPONENT GLYCOPYRROLATE; RefChem:663923; GLYCOPYRROLATE 1ML; Glycopyrrolate Oral Solution; A03AB02; R03BB06; Glycopyrrolate Injectable, Robinul-V; Glycopyrrolate Orally Disintegrating Tablets; 209-887-0; (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate; V92SO9WP2I; Glycopyrrolate bromide; Gastrodyn; Asecryl; MFCD00072137; threo-Glycopyrronium bromide; Robinal; C19H28BrNO3; DTXSID6023109; Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-,bromide; 3-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide; Glycopyrronium (bromide);Glycopyrrolate (bromide); DTXCID103109; Copyrrolate; Pyrrolidinium,1-dimethyl-, bromide; Seebri Breezhaler; SMR000469282; AHR 504; Glycopyrronii bromidum [INN-Latin]; NCGC00179456-02; WLN: T5KTJ A1 A1 COVXQR&- AL5TJ &Q &E; EINECS 209-887-0; NSC 250836; NSC 251251; NSC 251252; Bromure de glycopyrronium [INN-French]; Bromuro de glicopirronio [INN-Spanish]; Glycopyrrolate [USAN:USP]; Glycopyrrolate?; Lonhala Magnair; Pyrrolidinium,1-dimethyl-, bromide, .alpha.-cyclopentylmandelate; 1,1-Dimethyl-3-hydroxypyrrolidinium bromide .alpha.-cyclopentylmandelate; 1-Methyl-3-pyrrolidinyl .alpha.-phenylcyclopentaneglycolate methobromide; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide-.alpha.-cyclopentylmandelate; Mandelic acid, ester with 3-hydroxy-1,1-dimethylpyrrolidinium bromide; Cuvposa (TN); Robinul (TN); Glycopyrrolate (USP); .beta.-1-Methyl-3-pyrrolidyl-.alpha.-cyclopentylmandelate methobromide; Seebri breezhaler (TN); Glycopyrrolate (Standard); CAS-596-51-0; GLYCOPYRRONE BROMIDE; (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate bromide; NVP-NVA237; SCHEMBL41436; MLS001424112; MLS002222301; Glycopyrronium impurity N CRS; orb1305554; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide .alpha.-cyclopentylmandelate; CHEMBL1201027; GLXC-07572; Glycopyrrolate, >=98% (HPLC); Glycopyrronium bromide (JAN/INN); HMS1570E14; HMS2051P12; HMS2094A05; HMS2097E14; HMS2235F12; HMS3259P04; HMS3369F10; HMS3393P12; HMS3714E14; HMS3885P14; HMS5083I10; Pharmakon1600-01505753; CHF-5992; EX-A4155; Tox21_113144; Tox21_113145; EBC-26943; HY-17465R; MSK158426; NSC759238; s4660; 3-(2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidinium Bromide; AKOS015962136; Pyrrolidinium, 1,1-dimethyl-3-hydroxy-, bromide, alpha-cyclopentylmandelate; Tox21_113144_1; CCG-101030; CCG-213543; CS-1763; FG33643; NC00280; NC00694; NSC-759238; (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate;bromide; NCGC00179456-04; AC-23382; DA-63825; HY-17465; SY076375; G0392; NS00080268; D00540; EN300-7405787; SR-01000763650; SR-01000763650-3; Q27162963; 1,1-Dimethyl-3-hydroxypyrrolidinium bromide |A-cyclopentylmandelate; 1,1-dimethyl-3-hydroxypyrrolidiniumbromidealpha-cyclopentylmandelate; Glycopyrrolate, United States Pharmacopeia (USP) Reference Standard; Glycopyrronium bromide, European Pharmacopoeia (EP) Reference Standard; Glycopyrronium impurity N, European Pharmacopoeia (EP) Reference Standard; (1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate;bromide; 3-(2-cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-iumbromide; 3-[(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidin-1-ium bromide; 3-{[Cyclopentyl(hydroxy)(phenyl)acetyl]oxy}-1,1-dimethylpyrrolidin-1-ium bromide; 3-{[cyclopentyl(hydroxy)phenylacetyl]oxy}-1,1-dimethylpyrrolidin-1-ium bromide; alpha-cyclopentylmandelic acid ester with 3-hydroxy-1,1-dimethylpyrrolidinium bromide; Glycopyrronium for peak identification, European Pharmacopoeia (EP) Reference Standard동의어